Gaurav Syal1, Mariastella Serrano2, Animesh Jain3, Benjamin L Cohen4, Florian Rieder4, Christian Stone5, Bincy Abraham6, David Hudesman7, Lisa Malter8, Robert McCabe9, Stefan Holubar4, Anita Afzali10, Adam S Cheifetz11, Jill K J Gaidos12, Alan C Moss13. 1. Cedars-Sinai Medical Center, Los Angeles, California, USA. 2. MedStar Georgetown University Hospital, Washington DC, USA. 3. University of North Carolina, Chapel Hill, North Carolina, USA. 4. Cleveland Clinic, Cleveland, Ohio, USA. 5. Comprehensive Digestive Institute of Nevada, Las Vegas, Nevada, USA. 6. Houston Methodist Hospital, Houston, Texas, USA. 7. New York University Langone Medical Center, New York, New York, USA. 8. NYU Grossman School of Medicine, Bellevue Hospital Center, New York, New York, USA. 9. MNGI Digestive Health, Plymouth, Minnesota, USA. 10. Ohio State University Wexner Medical Center, Columbus, Ohio, USA. 11. Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 12. Yale University, New Haven, Connecticut, USA. 13. Boston University School of Medicine, Boston, Massachusetts, USA.
Abstract
BACKGROUND: With the management of inflammatory bowel disease (IBD) becoming increasingly complex, incorporating preventive care health maintenance measures can be challenging. The aim of developing these updated recommendations is to provide more specific details to facilitate their use into a busy clinical practice setting. METHOD: Fifteen statements were formulated with recommendations regarding the target, timing, and frequency of the health maintenance interventions in patients with IBD. We used a modified Delphi method and a literature review to establish a consensus among the panel of experts. The appropriateness of each health maintenance statement was rated on a scale of 1 to 5 (1-2 as inappropriate, and 4-5 as appropriate) by each panelist. Interventions were considered appropriate, and statements were accepted if ≥80% of the panelists agreed with a score ≥4. RESULTS: The panel approved 15 health maintenance recommendations for adults with IBD based on the current literature and expert opinion. These recommendations include explicit details regarding specific screening tools, timing of screening, and vaccinations for adults with IBD. CONCLUSIONS: Patients with IBD are at an increased risk for infections, malignancies, and other comorbidities. Given the complexity of caring for patients with IBD, this focused list of recommendations can be easily incorporated in to clinical care to help eliminate the gap in preventative care for patients with IBD.
BACKGROUND: With the management of inflammatory bowel disease (IBD) becoming increasingly complex, incorporating preventive care health maintenance measures can be challenging. The aim of developing these updated recommendations is to provide more specific details to facilitate their use into a busy clinical practice setting. METHOD: Fifteen statements were formulated with recommendations regarding the target, timing, and frequency of the health maintenance interventions in patients with IBD. We used a modified Delphi method and a literature review to establish a consensus among the panel of experts. The appropriateness of each health maintenance statement was rated on a scale of 1 to 5 (1-2 as inappropriate, and 4-5 as appropriate) by each panelist. Interventions were considered appropriate, and statements were accepted if ≥80% of the panelists agreed with a score ≥4. RESULTS: The panel approved 15 health maintenance recommendations for adults with IBD based on the current literature and expert opinion. These recommendations include explicit details regarding specific screening tools, timing of screening, and vaccinations for adults with IBD. CONCLUSIONS: Patients with IBD are at an increased risk for infections, malignancies, and other comorbidities. Given the complexity of caring for patients with IBD, this focused list of recommendations can be easily incorporated in to clinical care to help eliminate the gap in preventative care for patients with IBD.
Authors: Gurtej Malhi; Amir Rumman; Reka Thanabalan; Kenneth Croitoru; Mark S Silverberg; A Hillary Steinhart; Geoffrey C Nguyen Journal: J Crohns Colitis Date: 2015-04-23 Impact factor: 9.071
Authors: Jérémie Sellam; Haifa Hamdi; Carine Roy; Gabriel Baron; Marc Lemann; Xavier Puéchal; Maxime Breban; Francis Berenbaum; Marc Humbert; Karin Weldingh; Dominique Salmon; Philippe Ravaud; Dominique Emilie; Xavier Mariette Journal: Ann Rheum Dis Date: 2007-04-24 Impact factor: 19.103
Authors: Loni Berkowitz; Bárbara M Schultz; Geraldyne A Salazar; Catalina Pardo-Roa; Valentina P Sebastián; Manuel M Álvarez-Lobos; Susan M Bueno Journal: Front Immunol Date: 2018-01-30 Impact factor: 7.561
Authors: Choon Kin Lee; Sunny H V Wong; Grace Lui; Whitney Tang; Lai San Tam; Margaret Ip; Esther Hung; Minhu Chen; Justin C Wu; Siew C Ng Journal: J Crohns Colitis Date: 2018-07-30 Impact factor: 9.071